Overdose how excessive government regulation stifles pharmaceutical innovation

Epstein, Richard Allen

Overdose how excessive government regulation stifles pharmaceutical innovation - New Haven Yale University Press 2006 - xi, 283 p. 25 cm

"An Institute for Policy Innovation Book."

Includes bibliographical references (p. 241-271) and index.

Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines.

9780300116649

2006006514

GBA667981 bnb

101271119 DNLM 013526886 Uk


United States--Food and Drug Administration


Pharmaceutical industry--Government policy--United States
Drug Industry--United States
Government Regulation--United States
Public Policy--United States

HD9666.6 / .E67 2006

338.4761510973 / EP-O

QV 736 / E64o 2006

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library